Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Raw Materials (2017 - 2025)

Bioceres Crop Solutions' Raw Materials history spans 9 years, with the latest figure at $19.3 million for Q2 2025.

  • For Q2 2025, Raw Materials fell 14.46% year-over-year to $19.3 million; the TTM value through Jun 2025 reached $19.3 million, down 14.46%, while the annual FY2025 figure was $19.3 million, 14.46% down from the prior year.
  • Raw Materials for Q2 2025 was $19.3 million at Bioceres Crop Solutions, down from $22.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $24.9 million in Q2 2023 and bottomed at $3.3 million in Q4 2021.
  • The 5-year median for Raw Materials is $18.4 million (2022), against an average of $15.6 million.
  • The largest annual shift saw Raw Materials skyrocketed 177.42% in 2022 before it decreased 14.46% in 2025.
  • A 5-year view of Raw Materials shows it stood at $3.3 million in 2021, then skyrocketed by 429.58% to $17.5 million in 2022, then soared by 41.97% to $24.9 million in 2023, then dropped by 9.43% to $22.5 million in 2024, then dropped by 14.46% to $19.3 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Raw Materials are $19.3 million (Q2 2025), $22.5 million (Q2 2024), and $24.9 million (Q2 2023).